In this session, our panelists will navigate the legal nuances and practical implications of patent reissue and reexamination in Hatch-Waxman litigation. Topics of discussion will include:

• Assessing how these processes can influence the strength, scope, and enforceability of pharmaceutical patents
• Understanding the impact on market exclusivity, generic drug entry, and patient access to affordable medications
• Analyzing the key considerations when deciding to pursue reissue/reexaminaiton in a Hatch-Waxman scenario
• Grounds for filing
• Process before USPTO
• Timing
• Identifying the risks and limitations of utilizing reissue proceedings to resolve patent errors
• Employing a cost-benefit analysis while your patent application is pending
• Reconciling when supplemental examination is beneficial relative to reissue